Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
February 6, 2023JAMA NeurologyOpen Access

Prediction of Longitudinal Cognitive Decline in Preclinical Alzheimer Disease Using Plasma Biomarkers

View Full Paper
Ask AI
Bookmark
Share

Authors

NMNiklas MattssonUniversity of Southern CaliforniaGSGemma SalvadóLund UniversityNANicholas J. AshtonAlzheimer's Association

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Mattsson et al. (2023) studied this question.

synapsesocial.com/papers/69dcd1230de68e8319e53a49https://doi.org/10.1001/jamaneurol.2022.5272
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Increased amyloidogenic APP processing in APOE ɛ4-negative individuals with cerebral β-amyloidosis2016 · 64 citations
  2. 2Soluble P‐tau217 reflects amyloid and tau pathology and mediates the association of amyloid with tau2021 · 269 citations
  3. 3The Alzheimer's Association appropriate use recommendations for blood biomarkers in Alzheimer's disease2022 · 628 citations